Category: Home

Oxidative stress and inflammation

Oxidative stress and inflammation

In AMI a signaling cascade induces the expression inflsmmation recruitment anr proinflammatory CGM technology innovations, accelerating both knflammation and Oxidative stress and inflammation repair of infalmmation cardiac tissue. NADPH oxidase in humans was thought Oxidative stress and inflammation be sttess specific as the two membrane bound units, gp91 phox and p22 phox form a heterodimer and mediate bacterial killing by generating O 2 gp91 phox produces a burst of O 2 and p22 phox acts to stabilize gp91 phoxenhancing O 2 production [ ]. Abstract Both oxidative stress and inflammation are interdependent cellular consequences of a biological defense system, which can fuel cancer and other pathophysiological provenience.

Oxidative stress and inflammation -

However, the free radicals formed during physical activity regulate tissue growth and stimulate the production of antioxidants. Mild oxidative stress may also protect the body from infection and diseases.

In a study , scientists found that oxidative stress limited the spread of melanoma cancer cells in mice. This can contribute to aging and may play an important role in the development of a range of conditions.

Immune cells called macrophages produce free radicals while fighting off invading germs. These free radicals can damage healthy cells, leading to inflammation.

Under normal circumstances, inflammation goes away after the immune system eliminates the infection or repairs the damaged tissue. However, oxidative stress can also trigger the inflammatory response, which, in turn, produces more free radicals that can lead to further oxidative stress, creating a cycle.

Chronic inflammation due to oxidative stress may lead to several conditions, including diabetes, cardiovascular disease, and arthritis.

The brain is particularly vulnerable to oxidative stress because brain cells require a substantial amount of oxygen. According to a review , the brain consumes 20 percent of the total amount of oxygen the body needs to fuel itself.

Brain cells use oxygen to perform intense metabolic activities that generate free radicals. These free radicals help support brain cell growth, neuroplasticity, and cognitive functioning.

Oxidative stress also alters essential proteins, such as amyloid-beta peptides. According to one systematic review , oxidative stress may modify these peptides in way that contributes to the accumulation of amyloid plaques in the brain.

It is important to remember that the body requires both free radicals and antioxidants. Having too many or too few of either may lead to health problems.

Maintaining a healthy body weight may help reduce oxidative stress. According to a systematic review , excess fat cells produce inflammatory substances that trigger increased inflammatory activity and free radical production in immune cells.

The body produces free radicals during normal metabolic processes. Oxidative stress can damage cells, proteins, and DNA, which can contribute to aging. The body naturally produces antioxidants to counteract these free radicals.

Making certain lifestyle and dietary changes may help reduce oxidative stress. These may include maintaining a healthy body weight, regularly exercising, and eating a balanced, healthful diet rich in fruits and vegetables. Free radicals are unstable atoms that can cause damage to cells and lead to illnesses and the aging process.

Exactly what impact do they have on the…. A new study reviews the effects of exercising in older life. Greater independence and higher self-worth are only some of the benefits of physical….

The DNA in our cells holds not only the key to life, but also the reason we age. With every cell division, chromosomes shorten and cause the cell to…. Exercise is known to stave off the effects of aging, but how it manages this at a cellular level is not understood.

A new study focuses on…. Recent research suggests that people who play an instrument may experience protective effects on working memory, while those who things may have…. My podcast changed me Can 'biological race' explain disparities in health? Why Parkinson's research is zooming in on the gut Tools General Health Drugs A-Z Health Hubs Health Tools Find a Doctor BMI Calculators and Charts Blood Pressure Chart: Ranges and Guide Breast Cancer: Self-Examination Guide Sleep Calculator Quizzes RA Myths vs Facts Type 2 Diabetes: Managing Blood Sugar Ankylosing Spondylitis Pain: Fact or Fiction Connect About Medical News Today Who We Are Our Editorial Process Content Integrity Conscious Language Newsletters Sign Up Follow Us.

Medical News Today. Health Conditions Health Products Discover Tools Connect. How does oxidative stress affect the body? Medically reviewed by Stacy Sampson, D. What is it? Free radicals Antioxidants Effects Conditions Risk factors Prevention Summary Oxidative stress is an imbalance of free radicals and antioxidants in the body, which can lead to cell and tissue damage.

What is oxidative stress? Share on Pinterest Many lifestyle factors can contribute to oxidative stress. Healthy aging resources To discover more evidence-based information and resources for healthy aging, visit our dedicated hub. Was this helpful?

What are free radicals? What are antioxidants? Share on Pinterest Fresh berries and other fruits contain antioxidants. Effects of oxidative stress.

Conditions linked to oxidative stress. Although L-FABP concentration is significantly increased in CIN patients after 24 hours, the specificity of this biomarker for CIN is low on account of a range of potential confounders [ ].

Tissue plasminogen activator tPA , a part of the serine protease family, is a plasma protein involved in the breakdown of blood clots and a key fibrinolytic agent that takes part in the recruitment of inflammatory cells.

Some other roles of tPA involve the turnover of extracellular matrix components via activation of matrix metalloproteinases and immune-modulatory functions. Plasminogen activator inhibitor-1 is the main physiological inhibitor of endogenous fibrinolysis which functions through the inhibition of tPA and the urokinase type activator uPA [ , ].

A recent study [ ] reported a relationship between increased serum tPA levels with an increased rate of mortality of dialysis-dependent AKI AKI-D patients. Elevated tPA expression has been detected in the proximal tubular epithelial cells of ischemic kidneys, in animal models.

Removing tPA by antisense treatment had reduced the influx of neutrophils and helped protect renal function during ischemia-reperfusion injury. This suggests tPA inhibition as a novel strategy to improve ischemic AKI [ ]. Many additional studies have also implied the involvement of tPA in the process of kidney fibrosis that leads to progression of CKD [ - ].

IL-6 is an interleukin that can act as both an anti-inflammatory myokine and a pro-inflammatory cytokine and is encoded by the IL6 gene in humans.

Osteoblasts produce and release IL The role of IL-6 role as an anti-inflammatory cytokine is facilitated via the interleukins inhibitory effects on IL-1 and TNF-α, and activation of IL and IL-1ra [ ]. Studies have demonstrated a close correlation between AKI and IL-6 expression in many animal models [ , ].

Resident kidney cells, such as tubular epithelial cells, endothelial cells, mesangial cells and podocytes can all produce and release IL A study has shown that, in a model of ischemia-reperfusion injury, after leukocytes penetrated the injured kidney, maladaptive IL-6 was produced in response to their TLR-4 receptors interacting with high mobility group box 1 protein released by the injured renal cells [ ].

Raised levels of the pro-inflammatory cytokines, IL-8 and IL-6, have been seen early on in AKI patients and were linked to prolonged mechanical ventilation [ ]. The transmembrane protein, kidney injury molecule 1 KIM-1 , recognizes apoptotic cells and leads them to lysosomes.

Additionally, it acts as a receptor for oxidized lipoproteins and is therefore adept at recognizing apoptotic cell signals. KIM-1 is undetectable in normal kidney tissue but is highly expressed following toxic or ischaemic injury in differentiated proximal tubule epithelial cells from rodent and human kidneys [ , ].

Plasma cystatine-C CysC , is a low molecular weight protein produced at a predictable rate by all nucleated cells. CysC is filtered across the glomerular membrane but is neither reabsorbed nor secreted during its passage through the nephron.

Given that CysC is almost entirely catabolized in the proximal tubule, it is impossible to measure its renal clearance. However, the plasma or serum concentration of CysC accurately reflects the GFR and significant increases in CysC are detected in CIN patients after 8 h.

However, a similar increment has also been seen in several other conditions, including thyroid dysfunction, age, an increase in muscle mass, systemic inflammation, corticosteroids administration and neoplasia [ ] limiting its utility as a CIN biomarker. Other laboratory findings may also be present such as hyperkalaemia and acidosis.

Findings on urine analysis are normally non-specific [ ]. Normally a delay of h is seen between contrast exposure and changes in serum creatinine concentration, which makes creatinine a late indicator of renal function changes [ ].

Since a close correlation among inflammatory molecules and kidney injury in CIN has been observed, as described above, they have also been proposed as potential CIN biomarkers [Table 1]. IL-8 and IL-6, have been seen early on in AKI patients and were linked to prolonged mechanical ventilation [ ].

Successive studies have recognized renal NGAL as a unique, specific biomarker for the early detection of AKI in critically ill patients and after CM administration [ - ].

Other proposed biomarkers, despite being effective predictors of AKI, such as uNGAL triggered preceding increases in serum creatinine concentration [ , ] are still experimental.

Other potential biomarkers have been deemed as non-specific, such as L-FABP, although significantly increased in CIN patients after 24 h, where potential confounders lower its specificity [ ]. Oxidative stress influences cardiovascular morbidity mainly through increased peripheral vascular resistance [Figure 1].

However, although the generation of ROS could affect renal blood flow by facilitating the production of vasoconstrictors and impacting the effects of vasodilators, the influence of oxidative stress in the development of CIN is uncertain. Inflammation results in the alteration of homeostasis in both the circulatory and renal systems.

These alterations can be intrinsic of cellular damage or can be mediated by external factors such as CM. Immune response to CM cytotoxicity causes a rapid increase in the migration and accumulation of cytokines such as ILs and TNF-α in the progression of both CVD and CIN.

Additionally, the presence of cellular types found in response to inflammation is a feature in early development of CVD and CIN. The main interplay between CIN and CVD in the context of inflammation may rely on endothelial dysfunction and immune response.

The signaling pathways activated through endothelial dysfunction in cardiac events result in the generation of systemic inflammation which has been found to affect the kidneys and made them more susceptible to local inflammation processes driven by CM cytotoxicity.

Current CIN prevention strategies, such as the use of carotenoids, for instance curcumin and lycopene [ , ] , to limit the oxidative effects of CM are questionable due to the inconclusive evidence to support the oxidative capacity of CM.

Existing biomarkers for CIN are either non-specific, such as L-FABP, or late indicators of renal function changes, such as changes in serum creatinine, making them poor predictive markers at best. The relationship between CVD and CIN and the underlying mechanisms responsible for CIN are unclear.

Identifying novel biomarkers, be it genetic, redox or serum protein markers, for the early detection of CIN will help gain a better understanding of the underlying mechanisms. Greater mechanistic understanding is required to better predict and treat CIN. Original draft text editing: Cervantes-Gracia K, Raja K, Llanas-Cornejo D, Cobley JN, Megson IL, Chahwan R, Husi H.

Cervantes-Gracia K is supported by CONACYT Mexico scholarship No. Chen L, Deng H, Cui H, Fang J, Zuo Z, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget ; Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB.

Reactive oxygen species in inflammation and tissue injury. Antioxidants Redox Signal ; Kim YM, Kim SJ, Tatsunami R, Yamamura H, Fukai T, et al. ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis. Am J Physiol - Cell Physiol ;C Chelombitko MA. Role of reactive oxygen species in inflammation: a minireview.

Moscow Univ Biol Sci Bull ; Yang W, Tao Y, Wu Y, Zhao X, Ye W, et al. Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair.

Nat Commun ; Dröge W. Free radicals in the physiological control of cell function. Physiol Rev ; Cai Z, Yan LJ. Protein oxidative modifications: beneficial roles in disease and health. J Biochem Pharmacol Res ; Cobley JN, Husi H. Immunological techniques to assess protein thiol redox state: opportunities, challenges and solutions.

Antioxidants ; Ranneh Y, Ali F, Akim AM, Hamid HA, Khazaai H, et al. Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review. Appl Biol Chem ; Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked?

Free Radic Biol Med ; Austin V, Crack PJ, Bozinovski S, Miller AA, Vlahos R. COPD and stroke: are systemic inflammation and oxidative stress the missing links?

Clin Sci ; Rovira-Llopis S, Rocha M, Falcon R, de Pablo C, Alvarez A, et al. Is myeloperoxidase a key component in the ROS-induced vascular damage related to Nephropathy in type 2 diabetes?

Hansen PR. Chronic inflammatory diseases and atherosclerotic cardiovascular disease: innocent bystanders or partners in crime? Curr Pharm Des ; Lorenzatti AJ, Servato ML.

New evidence on the role of inflammation in CVD risk. Curr Opin Cardiol ; Cervantes Gracia K, Llanas-Cornejo D, Husi H. CVD and oxidative stress. J Clin Med ; Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, et al. Eur Heart J ; Vasan RS, Short MI, Niiranen TJ, Xanthakis V, DeCarli C, et al.

Interrelations between arterial stiffness, target organ damage, and cardiovascular disease outcomes. J Am Heart Assoc ;8:e Briasoulis A, Bakri GL. Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep ; Yuan J, Zou XR, Han SP, Cheng H, Wang L, et al.

Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease C-STRIDE. BMC Nephrol ; Tomey MI, Winston JA. Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health.

Ann Glob Health ; Subbiah AK, Chhabra YK, Mahajan S. Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup. Heart Asia ; Rahman M, Xie D, Feldman HI, Go AS, He J, et al. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC study.

Am J Nephrol ; Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol ; Pyxaras SA, Sinagra G, Mangiacapra F, Perkan A, Di Serafino L, et al. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.

Am J Cardiol ; Sato A, Aonuma K, Watanabe M, Hirayama A, Tamaki N, et al. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: from the CINC-J study.

Int J Cardiol ; Rear R, Bell RM, Hausenloy DJ, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart ; Hossain MA, Costanzo E, Cosentino J, Patel C, Qaisar H, et al. Contrast-induced nephropathy: pathophysiology, risk factors, and prevention.

Saudi J Kidney Dis Transpl ; McDonald JS, McDonald RJ, Tran CL, Kolbe AB, Williamson EE, et al. Postcontrast acute kidney injury in pediatric patients: a cohort study.

Am J Kidney Dis ; Demirtas L, Turkmen K, Kandemir FM, Ozkaraca M, Kucukler S, et al. The possible role of interleukin as a new player in the pathogenesis of contrast-induced nephropathy in diabetic rats.

Ren Fail ; Oweis AO, Alshelleh SA, Daoud AK, Smadi MM, Alzoubi KH. Inflammatory milieu in contrast-induced nephropathy: a prospective single-center study. Int J Nephrol Renovasc Dis ; Yildirim E, Ermis E, Cengiz M. Inflammatory markers of contrast-induced nephropathy in patients with acute coronary syndrome.

Coron Artery Dis ; Murashima M, Nishimoto M, Kokubu M, Hamano T, Matsui M, et al. Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgery. Sci Rep ; de Souza Santos V, Peters B, Côco LZ, Alves GM, de Assis ALEM, et al.

Silymarin protects against radiocontrast-induced nephropathy in mice. Life Sci ; Kim JE, Bae SY, Ahn SY, Kwon YJ, Ko GJ. The role of nuclear factor erythroidrelated factor 2 expression in radiocontrast-induced nephropathy.

Kaptoge S, Pennells L, De Bacquer D, Cooney MT, Kavousi M, et al. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health ;7:e Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, et al.

Global, regional, and national age-sex-specific mortality for causes of death in countries and territories, a systematic analysis for the Global Burden of Disease Study Lancet ; Astin F, Jones K, Thompson DR. Prevalence and patterns of anxiety and depression in patients undergoing elective percutaneous transluminal coronary angioplasty.

Heart Lung ; Chhabra L, Zain MA, Siddiqui WJ. In: StatPearls. Treasure Island FL : StatPearls Publishing; Nadolski GJ, Stavropoulos SW. Contrast alternatives for iodinated contrast allergy and renal dysfunction: options and limitations. J Vasc Surg ; Schraeder R. Contrast media selection in interventional cardiology.

J Clin Basic Cardiol ; Al Shammeri O, Garcia LA. Thrombolysis in the age of primary percutaneous coronary intervention: mini-review and meta-analysis of early PCI.

Int J Health Sci Qassim ; Barauskas M, Unikas R, Tamulenaite E, Unikaite R. The impact of clinical and angiographic factors on percutaneous coronary angioplasty outcomes in patients with acute ST-elevation myocardial infarction.

Arch Med Sci Atheroscler Dis ;1:e Darvishpour A, Javadi-Pashaki N, Salari A, Sadeghi T, Taleshan-Nejad M.

Factors associated with quality of life in patients undergoing coronary angioplasty. Kim MJ, Jeon DS, Gwon HC, Kim SJ, Chang K, et al.

J Korean Med Sci ; Mandal A, Paudel MS, Kafle P, Khalid M, Bhattarai B, et al. Contrast-induced nephropathy following percutaneous coronary intervention at a tertiary cardiac center in Nepal. Cureus ;e Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, et al. Manske CL, Sprafka JM, Strony JT, Wang Y.

Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med ; Diamantopoulos A, Patrone L, Santonocito S, Theodoulou I, Ilyas S, et al. Carbon dioxide angiography during peripheral angioplasty procedures significantly reduces the risk of contrast-induced nephropathy in patients with chronic kidney disease.

CVIR Endovasc ; Ghumman SS, Weinerman J, Khan A, Cheema M, Levin D, et al. Contrast-induced nephropathy following peripheral angiography with carbon dioxide versus iodinated contrast media: a systematic review and meta-analysis of current literature. J Am Coll Cardiol ; Andreis A, Budano C, Levis M, Garrone P, Usmiani T, et al.

Contrast-induced kidney injury: how does it affect long-term cardiac mortality? J Cardiovasc Med ; Neyra JA, Shah S, Mooney R, Jacobsen G, Yee J, et al. Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease.

Nephrol Dial Transplant ; Schilp J, De Blok C, Langelaan M, Spreeuwenberg P, Wagner C. Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy. Haq MFU, Yip CS, Arora P. The conundrum of contrast-induced acute kidney injury.

J Thorac Dis ; Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.

Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, et al.

Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR cath-PCI registry.

JACC Cardiovasc Interv ; Watabe H, Sato A, Hoshi T, Takeyasu N, Abe D, et al. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention.

Berwanger O. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: Main results from the randomized acetylcysteine for contrast-induced nephropathy trial ACT. Circulation ; Bolognese L, Falsini G, Schwenke C, Grotti S, Limbruno U, et al.

Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Mohammed NA, Rafie I, Mahfouz A, Achkar K, Hajar R. Heart Views ; McCullough PA, Soman SS. Crit Care Clin ; Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, Heretis I, Wilks MF, et al. Contrast-induced nephropathy: basic concepts, pathophysiological implications and prevention strategies. Pharmacol Ther ; Solomon R, Dauerman HL.

Contrast-induced acute kidney injury. Morcos R, Kucharik M, Bansal P, Al Taii H, Manam R, et al. Contrast-induced acute kidney injury: review and practical update.

Clin Med Insights Cardiol ; Ward DB, Valentovic MA. Contrast induced acute kidney injury and direct cytotoxicity of iodinated radiocontrast media on renal proximal tubule cells.

J Pharmacol Exp Ther ; Celik T, Yilmaz MI, Balta S, Ozturk C, Unal HU, et al. The relationship between plasma whole blood viscosity and cardiovascular events in patients with chronic kidney disease. Clin Appl Thromb ; Peters SAE, Woodward M, Rumley A, Tunstall-Pedoe HD, Lowe GDO.

Plasma and blood viscosity in the prediction of cardiovascular disease and mortality in the Scottish Heart Health Extended Cohort Study. Eur J Prev Cardiol ; Sugimori H, Tomoda F, Koike T, Kurosaki H, Masutani T, et al.

Increased blood viscosity is associated with reduced renal function and elevated urinary albumin excretion in essential hypertensives without chronic kidney disease. Hypertens Res ; Ferrario CM, Mullick AE. Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.

Pharmacol Res ; Gavras I, Gavras H. Angiotensin II as a cardiovascular risk factor. J Hum Hypertens ;16 Suppl 2:S Ibrahim NE, Shrestha S, McCarthy C, Lyass A, Li Y, et al. J Am Coll Cardiol ;A Ozkok S, Ozkok A. Contrast-induced acute kidney injury: A review of practical points.

World J Nephrol ; Reiss AB, Grossfeld D, Kasselman LJ, Renna HA, Vernice NA, et al. Adenosine and the cardiovascular system. Am J Cardiovasc Drugs ; Huang YT, Chen YY, Lai YH, Cheng CC, Lin TC, et al.

Resveratrol alleviates the cytotoxicity induced by the radiocontrast agent, ioxitalamate, by reducing the production of reactive oxygen species in HK-2 human renal proximal tubule epithelial cells in vitro.

Int J Mol Med ; Jeong BY, Lee HY, Park CG, Kang J, Yu SL, et al. Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury. PLoS One ;e Chen Q, Zhang Y, Ding D, Xia M, Li D, et al.

Estimated glomerular filtration rate and mortality among patients with coronary heart disease. Dan Dunn J, Alvarez LAJ, Zhang X, Soldati T.

Reactive oxygen species and mitochondria: a nexus of cellular homeostasis. Redox Biol ; Murphy MP. How mitochondria produce reactive oxygen species. Biochem J ; Plotnikov EY, Pevzner IB, Zorova LD, Chernikov VP, Prusov AN, et al. Mitochondrial damage and mitochondria-targeted antioxidant protection in LPS-induced acute kidney injury.

Tang C, Han H, Yan M, Zhu S, Liu J, et al. Autophagy ; Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.

Biochim Biophys Acta - Mol Basis Dis ; Nicolson GL. Mitochondrial dysfunction and chronic disease: Treatment with natural supplements. Integr Med Encinitas ; Senoner T, Dichtl W. Oxidative stress in cardiovascular diseases: Still a therapeutic target? Nutrients ; Chistiakov DA, Shkurat TP, Melnichenko AA, Grechko AV, Orekhov AN.

The role of mitochondrial dysfunction in cardiovascular disease: a brief review. Ann Med ; Peoples JN, Saraf A, Ghazal N, Pham TT, Kwong JQ. Mitochondrial dysfunction and oxidative stress in heart disease. Exp Mol Med ; Siasos G, Tsigkou V, Kosmopoulos M, Theodosiadis D, Simantiris S, et al.

Mitochondria and cardiovascular diseases - from pathophysiology to treatment. Ann Transl Med ; Korge P, John SA, Calmettes G, Weiss JN.

Reactive oxygen species production induced by pore opening in cardiac mitochondria: the role of complex II. J Biol Chem ; Manskikh VN, Gancharova OS, Nikiforova AI, Krasilshchikova MS, Shabalina IG, et al.

Age-associated murine cardiac lesions are attenuated by the mitochondria-targeted antioxidant SkQ1. Histol Histopathol ; Behringer EJ, Segal SS. Impact of aging on calcium signaling and membrane potential in endothelium of resistance arteries: a role for mitochondria.

J Gerontol A Biol Sci Med Sci ; Bigelman E, Cohen L, Aharon-Hananel G, Levy R, Rozenbaum Z, et al. Pathological presentation of cardiac mitochondria in a rat model for chronic kidney disease.

Kocas C, Yildiz A, Abaci O, Karaca OS, Firdin N, et al. Platelet-to-lymphocyte ratio predicts contrast-induced nephropathy in patients with non-ST-segment elevation acute coronary syndrome. Angiology ; Yuan Y, Qiu H, Hu X, Luo T, Gao X, et al. Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention.

Clin Cardiol ; Zhao K, Li Y, Gao Q. Role of red blood cell distribution width in predicting contrast induced nephropathy in patients with stable angina pectoris undergoing percutaneous coronary intervention. Zorlu C, Koseoglu C. Comparison of the relationship between inflammatory markers and contrast-induced nephropathy in patients with acute coronary syndrome after coronary angiography.

Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal Syndrome. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med ; Schiffrin EL, Lipman ML, Mann JFE.

Chronic kidney disease: effects on the cardiovascular system. Tokuyama H, Kelly DJ, Zhang Y, Gow RM, Gilbert RE. Macrophage infiltration and cellular proliferation in the non-ischemic kidney and heart following prolonged unilateral renal ischemia.

Nephron Physiol ; Halliwell B. Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment.

Drugs Aging ; Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol ; Tang X, Luo YX, Chen HZ, Liu DP.

Mitochondria, endothelial cell function, and vascular diseases. Front Physiol ; Cobley J, Noble A, Bessell R, Guille M, Husi H. Reversible thiol oxidation inhibits the mitochondrial ATP synthase in xenopus laevis oocytes. Cobley JN, Noble A, Jimenez-Fernandez E, Valdivia Moya MT, Guille M, et al.

Catalyst-free Click PEGylation reveals substantial mitochondrial ATP synthase sub-unit alpha oxidation before and after fertilisation. Plotnikov EY, Zorov DB. Pros and cons of use of mitochondria-targeted antioxidants. Liguori I, Russo G, Curcio F, Bulli G, Aran L, et al.

Oxidative stress, aging, and diseases. Clin Interv Aging ; Abete P, Napoli C, Santoro G, Ferrara N, Tritto I, et al.

Age-related decrease in cardiac tolerance to oxidative stress. J Mol Cell Cardiol ; Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy.

Kidney Int ; Caiazza A, Russo L, Sabbatini M, Russo D. Hemodynamic and tubular changes induced by contrast media. Biomed Res Int ; Brinkley TE, Nicklas BJ, Kanaya AM, Satterfield S, Lakatta EG, et al.

Plasma oxidized low-density lipoprotein levels and arterial stiffness in older adults the health, aging, and body composition study.

Hypertension ; Zuliani G, Morieri ML, Volpato S, Vigna GB, Tch CB, et al. Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study. Atherosclerosis ; Burtenshaw D, Kitching M, Redmond EM, Megson IL, Cahill PA.

Reactive Oxygen Species ROS , Intimal Thickening, and Subclinical Atherosclerotic Disease. Front Cardiovasc Med ; Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL.

Oxidative stress in atherosclerosis. Curr Atheroscler Rep ; Rivera J, Sobey CG, Walduck AK, Drummond GR. Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep ; Craige SM, Kant S, Reif M, Chen K, Pei Y, et al.

Liu XH, Zhang QY, Pan LL, Liu SY, Xu P, et al. NADPH oxidase 4 contributes to connective tissue growth factor expression through Smad3-dependent signaling pathway. Gray SP, Di Marco E, Kennedy K, Chew P, Okabe J, et al. Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling.

Arterioscler Thromb Vasc Biol ; Wu RF, Ma Z, Liu Z, Terada LS. Nox4-derived H 2 O 2 mediates endoplasmic reticulum signaling through local ras activation. Mol Cell Biol ; Martin D, Li Y, Yang J, Wang G, Margariti A, et al. Unspliced X-box-binding protein 1 XBP1 protects endothelial cells from oxidative stress through interaction with histone deacetylase 3.

Mocellin S, Bronte V, Nitti D. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med Res Rev ; Lemkens P, Nelissen J, Meens MJPMT, Janssen BJA, Schiffers PMH, et al.

J Hypertens ; Barhoumi T, Briet M, Kasal DA, Fraulob-Aquino JC, Idris-Khodja N, et al. Erythropoietin-induced hypertension and vascular injury in mice overexpressing human endothelin exercise attenuated hypertension, oxidative stress, inflammation and immune response.

Uchmanowicz I. Oxidative stress, frailty and cardiovascular diseases: current evidence. Adv Exp Med Biol ; McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, et al. Risk prediction of contrast-induced nephropathy.

Am J Cardiol ;K Liu ZZ, Schmerbach K, Lu Y, Perlewitz A, Nikitina T, et al. Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback.

Am J Physiol Renal Physiol ;F Pisani A, Riccio E, Andreucci M, Faga T, Ashour M, et al. Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy. Briguori C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, et al.

Renal insufficiency after contrast media administration trial II REMEDIAL II : renalguard system in high-risk patients for contrast-induced acute kidney injury. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies.

CMAJ ; Briguori C, Donnarumma E, Quintavalle C, Fiore D, Condorelli G. Contrast-induced acute kidney injury: potential new strategies. Curr Opin Nephrol Hypertens ; Rezaee MA, Mohammadpour AH, Imenshahidi M, Mahmoudi M, Sankian M, et al. Protective effect of erythropoietin on myocardial apoptosis in rats exposed to carbon monoxide.

Gibson KR, Neilson IL, Barrett F, Winterburn TJ, Sharma S, et al. Evaluation of the antioxidant properties of N-acetylcysteine in human platelets: Prerequisite for bioconversion to glutathione for antioxidant and antiplatelet activity. J Cardiovasc Pharmacol ; Andreucci M, Faga T, Pisani A, Sabbatini M, Michael A.

Acute kidney injury by radiographic contrast media: pathogenesis and prevention. Kwasa EA, Vinayak S, Armstrong R. The role of inflammation in contrast-induced nephropathy. Br J Radiol ; Toso A, Leoncini M, Maioli M, Tropeano F, Di Vincenzo E, et al. Relationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study.

Kaya A, Kaya Y, Topçu S, Günaydın ZY, Kurt M, et al. Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention.

El Sayed AA, Haylor JL, El Nahas AM, Salzano S, Morcos SK. Haemodynamic effects of water-soluble contrast media on the isolated perfused rat kidney. Limbruno U, Caterina R.

Oxidative an plays Wholesome mineral supplements Oxidative stress and inflammation role in the pathogenesis of chronic diseases inflqmmation as cardiovascular diseases, iinflammation, neurodegenerative diseases, xOidative cancer. Long term exposure to increased levels of pro-oxidant factors can cause Oxidative stress and inflammation defects at a mitochondrial DNA level, as well as functional alteration of several Oxidativw and cellular structures Oidative to aberrations in gene expression. The modern lifestyle associated with processed food, exposure to a wide range of chemicals and lack of exercise plays an important role in oxidative stress induction. However, the use of medicinal plants with antioxidant properties has been exploited for their ability to treat or prevent several human pathologies in which oxidative stress seems to be one of the causes. In this review we discuss the diseases in which oxidative stress is one of the triggers and the plant-derived antioxidant compounds with their mechanisms of antioxidant defenses that can help in the prevention of these diseases. Both oxidative Oxidative stress and inflammation and inflaammation are interdependent cellular Oxidwtive of a biological defense system, Oxidative stress and inflammation can fuel cancer inflammstion other pathophysiological provenience. In recent past, several emerging evidences showed that prevalence Matcha green tea for concentration oxidative stress and inflammatkon promotes multiple oncogenic events, including cell proliferation, angiogenesis, migration, metabolic reprogramming, and evasion of regulated cell death in cancer cells. Oxidative stress and chronic inflammation contribute to the progression of cancer in a unanimous pattern with significant cellular signaling response and outcomes. However, both oxidative stress and inflammation are also associated with the pathogenesis of several other diseases. The oxidative stress is an imbalance between oxidant and antioxidant defense system, which in turn damaging the macromolecules and dysregulation of complex casacde of cell signaling.

Video

Oxidative Stress \u0026 Chronic Low-Grade Inflammation - PAN Academy - Free Online Nutrition Courses

Author: Kajas

5 thoughts on “Oxidative stress and inflammation

  1. Ich kann empfehlen, auf die Webseite vorbeizukommen, wo viele Informationen zum Sie interessierenden Thema gibt.

  2. Nach meiner Meinung sind Sie nicht recht. Geben Sie wir werden es besprechen. Schreiben Sie mir in PM.

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com